Explore
Validate
Learn
Flow cytometry
Other assayAntibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations
- Other assay [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- MHCD4504 - Provider product page
- Provider
- Invitrogen Antibodies
- Product name
- CD45 Monoclonal Antibody (HI30), PE
- Antibody type
- Monoclonal
- Antigen
- Other
- Description
- R-phycoerythrin (PE) is a stable and highly soluble phycobiliprotein which provides maximal absorbance and fluorescence without susceptibility to internal or external fluorescence quenching, thus providing an exceptional quantum yields and molar extinction coefficients.
- Reactivity
- Human
- Host
- Mouse
- Conjugate
- Yellow dye
- Isotype
- IgG
- Antibody clone number
- HI30
- Vial size
- 500 µL
- Storage
- 4° C, store in dark
Submitted references Physical exercise and human adipose-derived mesenchymal stem cells ameliorate motor disturbances in a male rat model of Parkinson's disease.
Enhancing the Activation and Releasing the Brakes: A Double Hit Strategy to Improve NK Cell Cytotoxicity Against Multiple Myeloma.
Sunitinib does not impair natural killer cell function in patients with renal cell carcinoma.
Analysis of the safety of mesenchymal stromal cells secretome for glioblastoma treatment.
Dynamic change in natural killer cell type in the human ocular mucosa in situ as means of immune evasion by adenovirus infection.
Cucarián JD, Berrío JP, Rodrigues C, Zancan M, Wink MR, de Oliveira A
Journal of neuroscience research 2019 Sep;97(9):1095-1109
Journal of neuroscience research 2019 Sep;97(9):1095-1109
Enhancing the Activation and Releasing the Brakes: A Double Hit Strategy to Improve NK Cell Cytotoxicity Against Multiple Myeloma.
Tognarelli S, Wirsching S, von Metzler I, Rais B, Jacobs B, Serve H, Bader P, Ullrich E
Frontiers in immunology 2018;9:2743
Frontiers in immunology 2018;9:2743
Sunitinib does not impair natural killer cell function in patients with renal cell carcinoma.
Moeckel J, Staiger N, Mackensen A, Meidenbauer N, Ullrich E
Oncology letters 2017 Jul;14(1):1089-1096
Oncology letters 2017 Jul;14(1):1089-1096
Analysis of the safety of mesenchymal stromal cells secretome for glioblastoma treatment.
Onzi GR, Ledur PF, Hainzenreder LD, Bertoni AP, Silva AO, Lenz G, Wink MR
Cytotherapy 2016 Jul;18(7):828-37
Cytotherapy 2016 Jul;18(7):828-37
Dynamic change in natural killer cell type in the human ocular mucosa in situ as means of immune evasion by adenovirus infection.
Yawata N, Selva KJ, Liu YC, Tan KP, Lee AW, Siak J, Lan W, Vania M, Arundhati A, Tong L, Li J, Mehta JS, Yawata M
Mucosal immunology 2016 Jan;9(1):159-70
Mucosal immunology 2016 Jan;9(1):159-70
No comments: Submit comment
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Morphological features and characterization of ADSCs. Our mesenchymal stromal cells had a spindle-shaped, fibroblast-like morphology, and demonstrated plastic adherent properties in culture. Cells underwent differentiation in (a) chondrocytes stained by Alcian blue; (c) Adipocytes showing some lipid vesicles stained by Oil red; and (e) osteoblasts, showing calcium phosphate stained with Alizarin red, after 3 weeks of induction. The negative controls, which received only the standard culture medium at the same time as those induced are showing for comparison (b,d,f). (g) Histograms of flow cytometry showing that these cells were homogeneously positive for mesenchymal markers: CD44, and CD105; but negative for hematopoietic markers: CD14, CD34, and CD45. Microphotograph scale = 50 mum [Color figure can be viewed at wileyonlinelibrary.com ]
- Conjugate
- Yellow dye
